uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Autoantibodies Against Soluble and Immobilized Human Recombinant Tissue Transglutaminase in Children with Celiac Disease.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Genetics and Pathology.
Show others and affiliations
2005 (English)In: J Pediatr Gastroenterol Nutr., Vol. 41, no 3, 322-327 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 41, no 3, 322-327 p.
National Category
Immunology in the medical area
URN: urn:nbn:se:uu:diva-96689OAI: oai:DiVA.org:uu-96689DiVA: diva2:171346
Available from: 2008-02-06 Created: 2008-02-06 Last updated: 2016-02-25
In thesis
1. The Significance of IgG Antibodies against Tissue Transglutaminase in Coeliac Disease
Open this publication in new window or tab >>The Significance of IgG Antibodies against Tissue Transglutaminase in Coeliac Disease
2008 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Coeliac disease (CD) is a multifactorial disease of the small intestine. In genetically predisposed individuals the, ingestion of cereals leads to a remodulation of the mucosal architecture, and the production of autoantibodies against tissue transglutaminase (tTG). The treatment is a lifelong gluten-free diet.

The diagnostic procedure relies on the examination of a small-bowel biopsy that displays villous atrophy. A spectrum of clinical manifestations is associated with CD, ranging from overt enteropathy to atypical and silent symptoms. Approximately 1% of the general population has CD, and the majority is undiagnosed. Although most patients with active CD can be detected by the assessment of elevated IgA-tTG, some patients lack these antibodies. Moreover, individuals with IgA-deficiency cannot be identified by means of IgA serology.

The aim of this thesis was to investigate the clinical utility of IgG-tTG for the detection and follow-up of subjects with active CD. The included studies showed that IgG-tTG was highly prevalent in IgA-deficient and IgA-competent patients with CD, whereas non-CD patients rarely had these antibodies. During a gluten-free diet, IgG-tTG decreased, demonstrating that IgG-tTG can be used to follow the patient’s adherence such a diet. Furthermore, 10% of healthy IgA deficient blood donors had elevated IgG-tTG, indicating that they had silent CD.

In IgA-competent subjects, high IgG-tTG levels correlated with a severe mode of CD and profound mucosal deterioration, suggesting that IgG-tTG might be involved in the disease progression. Moreover, we found that although a considerable percentage of IgA-competent patients lack IgG-tTG, the presence of these antibodies in conjunction with high levels of IgA-tTG was highly predictive of a severe small-intestine villous atrophy. It was also demonstrated that IgG-tTG normalisation coincided with clinical remission in IgA-competent CD patients on a gluten-free diet.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2008. 56 p.
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 307
Immunology, Coeliac disease, Tissue transglutaminase, Endomysium, IgG antibodies, Immunologi
urn:nbn:se:uu:diva-8424 (URN)978-91-554-7078-4 (ISBN)
Public defence
2008-02-27, Rudbecksalen, Rudbeck Laboratory, Dag Hammarskjölds väg 20, Uppsala, 13:15
Available from: 2008-02-06 Created: 2008-02-06Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Hansson, Tony
By organisation
Department of Genetics and Pathology
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 206 hits
ReferencesLink to record
Permanent link

Direct link